Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Free Report) in a research note published on Thursday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Price Performance Shares of NYSEAMERICAN AMPE opened at $0.23 on Thursday. The firm’s 50-day moving average is $0.25 and its two-hundred day […]

Related Keywords

Colorado ,United States ,Englewood , ,Hedge Funds Weigh In On Ampio Pharmaceuticals ,News Ratings For Ampio Pharmaceuticals Daily ,Millennium Management ,Ampio Pharmaceuticals ,Ampio Pharmaceuticals Inc ,Vanguard Group Inc ,Blackrock Inc ,Ampio Pharmaceuticals Price Performance ,Ampio Pharmaceuticals Company Profile ,Free Report ,Street Corp ,Two Sigma Advisers ,Sigma Advisers ,Ampio Pharmaceuticals Daily ,